Markets
paper Chinese yuan in piles
(Shutterstock)

The market wants more from China

The stock rally continued when China’s onshore market reopened, but traders were disappointed at the lack of further policies to save China’s sluggish economy

China’s market had an epic rally after China’s central bank unveiled a slew of monetary stimulus measures in September. 

A big question remained, though: how long will it last? We may have gotten some clues as the market reopened on Tuesday after a seven-day National Day holiday from October 1 to 7, as the policy-driven rally seemed to have lost some momentum. 

The CSI 300, which tracks the top 300 stocks traded on the Shanghai Stock Exchange and the Shenzhen Stock Exchange, surged nearly 11% during the market open on Tuesday. But the index eased some gains throughout the day to finish 6.1% up.

Meanwhile, Hong Kong’s benchmark index, Hang Seng, slumped 5.6% on Tuesday, wiping out all gains during the National Day holiday (the Hong Kong stock exchange was closed only on October 1).

The decline was partly due to a disappointing presser from China’s top economic planner. After late September’s stimulus — which included rate cuts, lower existing mortgage rates, lower required reserve ratio, and a 800-million-yuan liquidity support for the stock market — traders were expecting more details on fiscal stimulus from the government to get the economy back on track. That includes spending incentives, special bonds, and support for “new college graduates, migrant workers, the unemployed, elderly, and disabled,” analysts said.

But at its first post-holiday meeting, the National Development and Reform Commission (NDRC) “did not provide any more details around the shape and size of the fiscal support that has been announced,” Deutsche Bank analysts wrote in a note.

Wall Street was expecting somewhere between 2 trillion and 3 trillion yuan in fiscal packages. The NDRC, however, announced a modest 200 billion yuan (about $28.3 billion), 100 billion yuan of which was going to construction projects. 

Some China watchers said that the announcement wasn’t surprising, given how Chinese government agencies usually behave. NDRC’s main goal was likely not to meet the market where it was, but more to send a signal to top government officials about the intent to target the economy, notwithstanding concrete policies.

Still, the CSI 300 finished at another record high. ETFs that track China megacaps gained over 30% in the past month, outperforming the S&P 500.

The market vs. the economy

Broadly, analysts agree that the booming stock market doesn’t change the fundamentals of China’s economy, which has been on a downhill path since 2021. But degrees of optimism over the market rally differ. 

Goldman Sachs upgraded its call on Chinese offshore stocks (Chinese companies that trade in Hong Kong or the US) to overweight on October 7 and shifted its tactical preference from H-shares (that are traded in Hong Kong dollars) to A-shares (that are traded in Chinese yuan), saying in a note to clients that these stocks are more directly exposed to stock market stimulus and retail investors’ participation.

Indeed, the retail sentiment alone, independent of fiscal measures, was strong in China. State media reported a 4x to 6x surge in the number of new brokerage accounts, mostly from young people. ETF inflows and margin financing activities also rose. Shares of China’s brokerage software like Hithink Flush and East Money have more than doubled since September 23.

But others see the Chinese economy as a deeper problem. Adam Wolfe, emerging markets economist at Absolute Strategy Research, distinguished between the stimulus measures for the real economy and the stock market, calling the former “mostly incremental, small, and inconsequential,” while the latter was “new, unlimited, and significant.” 

Olivier d’Assier, Head of APAC, Investment Decision Research at SimCorp, said that China’s banking system is “teetering on the verge of collapse,” and the announced stimulus was not enough.

“It is $59 trillion in size and only $142 billion was announced to recapitalize it — compare this to a US banking system of $23.4 trillion, much better diversified than China’s, and where the Fed spent $475 billion to recapitalize it during the GFC,” he said.

“As for the market, this is a policy-driven rally. It won’t last and it won’t change the equation for investors — most of whom will not have bought at the bottom,” d’Assier added.

More Markets

See all Markets
markets

Nvidia and SK Hynix strike multiyear partnership on memory chips, AI data center build-out

Nvidia shares are modestly higher after it announced a multiyear partnership with SK Hynix on memory chips and building out AI data centers.

The agreement secures a long-term pipeline of memory chips for Nvidia. At the center of the partnership is the integration of SK Hynix’s high-bandwidth memory chips into Nvidia’s newly unveiled Vera central processing units. The Vera processor is Nvidia’s first stand-alone data center microprocessor designed to compete directly against traditional enterprise server lines.

The collaboration is also structured to reshape how semiconductors are manufactured. Under the terms of the agreement, SK Hynix will implement Nvidia’s CUDA-X library and PhysicsNeMo framework directly into its memory design and manufacturing workflows.

The announcement happened during a high-profile visit to Seoul by Nvidia CEO Jensen Huang, who arrived on June 5 to align with core infrastructure partners. Over the weekend, Huang met with SK Group Chairman Chey Tae-won, SK Hynix CEO Kwak Noh-Jung, and other top South Korean technology executives during a dinner meeting, according to Nvidia’s blog posts and Reuters.

Last week, SK Hynix told investors that its proposed US listing has received strong backing, which would potentially give US investors an alternative way to play the memory chip crunch.

markets

FuelCell Energy rises as AI data center pipeline overshadows Q2 miss

FuelCell Energy shares rebounded into positive territory during premarket trading, reversing an initial dip sparked by Q2 results that showed widening net losses and a year-over-year revenue decline.

Key numbers:

  • Revenue of $35.6 million (compared to analyst estimates of $40.56 million).

  • An adjusted loss per share of $1.45 (estimate: a $0.50 loss).

That revenue number marks a 5% decrease from the $37.4 million generated during the same quarter last year.

The company’s net loss expanded to $78.7 million, or $1.45 per share, compared to a loss of $38.8 million in the prior-year period. Management attributed the deeper loss primarily to a $42.6 million one-time impairment expense linked to essential equipment upgrades at its Groton Project facility.

While a 9.9% drop in total backlog initially added to the shares’ downward momentum, investors appeared to quickly pivot their attention to the company’s forward-looking metrics. FuelCell highlighted a 267% sequential jump in its sales pipeline, which has reached 4 gigawatts. The surge is driven by demand for its packaged 12.5-megawatt utility-grade power block solution tailored specifically for the booming AI data center market.

To support this high-growth data center strategy, FuelCell announced a major capacity expansion at its Torrington, Connecticut, manufacturing facility. The company plans to raise its annualized production ceiling from 350 MW to 500 MW, an infrastructure upgrade estimated to cost between $200 million and $275 million over the next 24 months.

Driven by the AI data center narrative, FuelCell Energy’s stock has risen over 130% year to date.

markets

Lilly says its next-gen GLP-1 shot drove 28.3% weight loss, reduced comorbidities

Eli Lilly has risen around 4% in premarket trading after reporting impressive trial results for its next-generation weight-loss drug over the weekend.

According to the results unveiled on Saturday, Lilly’s experimental weight-loss shot, retatrutide, helped patients lose 28.3% of their body weight at 80 weeks. That’s more than tirzepatide, Lilly’s weight-loss shot currently considered the most effective in the market, which helped people lose 26% of their weight over 88 weeks.

Retatrutide is a triple agonist, meaning it mimics three different hormones that promote weight loss, compared to one by Novo Nordisk’s semaglutide and two by tirzepatide. Lilly says it helps preserve more muscle mass than other weight-loss shots and also helped improve knee osteoarthritis pain and obstructive sleep apnea.

Lilly has said it would submit the drug for approval this year with the goal of getting it out to market in 2027. The jab could be the next big moneymaker for Lilly, which currently sells the most lucrative drug in the world but has had an underwhelming rollout of its oral weight-loss pill, which came to market earlier this year.

Retatrutide is already quite popular among those who experiment with peptides, or unapproved injectable drugs often sold online “for research purposes only.” For gym bros trying to attain a certain physique, a drug that has shown it can melt fat while preserving muscle is enticing.

But in a market full of knockoff drugs, will retatrutide enthusiasts pay full price for the drug when it officially goes to market?

markets

Marvell and Flex rise on S&P 500 inclusion announcement

Chipmaker Marvell Technology and electronics manufacturer Flex are jumping 7% and 3%, respectively, in premarket trading on Monday after S&P Dow Jones Indices announced late on Friday that the two companies are set to join the S&P 500 benchmark index.

Replacing Pool Corp. and Campbell’s in the S&P 500, Marvell and Flex’s addition will be effective from June 22, per a press release from the provider, which assesses and updates the index on a quarterly basis.

Marvell has been one of the leading candidates for inclusion across the last few quarterly index rebalances. The company has ballooned into a $230 billion chip giant of late, thanks to the wider AI boom, investors chasing momentum, and, yes, Jensen Huang. Flex, which has been part of the S&P MidCap 400 Index since 2024, has also grown recently, having played a part in the data center boom with a portfolio that spans across infrastructure and cooling systems.

With today’s premarket movement taken into account, MRVL has now risen almost 40% in the last week alone.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.